Limited Competition for Fragile X Research Center Revision Applications (P30)

The summary for the Limited Competition for Fragile X Research Center Revision Applications (P30) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for Fragile X Research Center Revision Applications (P30): - Purpose. The original RFA for Fragile X syndrome Research Centers was developed in response to the Children's Health Act of 2000 (H. R. 4365) Section 452E and funded three successful applications. It is the purpose of this RFA to maintain the momentum of discovery and further develop research relevant to Fragile X syndrome and associated disorders. The Fragile X Research Centers are intended to stimulate the formation of multidisciplinary, multi-institutional teams with a goal of facilitating the translation of basic research findings related to Fragile X syndrome from bench-to-bedside-to-community. -Mechanism of Support. This limited competition RFA will use the NIH Center Core Grant (P30) funding mechanism. Awards will be made for Centers-within-Centers as revisions (formerly called supplements) to existing Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Core Grants (P30). - Funds Available and Anticipated Number of Awards. The NICHD anticipates making up to three awards in response to this RFA. The NICHD intends to commit up to $4 million total costs annually for this program.

Federal Grant Title:	Limited Competition for Fragile X Research Center Revision Applications (P30)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-07-013
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	May 26, 2007
Posted Date:	Mar 23, 2007
Creation Date:	Mar 23, 2007
Archive Date:	Jun 25, 2007
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:	$1,330,000
Minimum Federal Grant Award:
Expected Number of Awards:	3
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Any currently funded NICHD MRDDRC with scientific personnel and institutional resources capable of providing a strong research base in Fragile X is eligible. Individual MRDDRCs may submit one application, but a given application may involve multiple sites, including other MRDDRCs and partners that may be domestic or foreign non-profit and for-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State or local government; and eligible agencies of the Federal government.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical...; • Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial No...; • Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P5...; • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...; • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...; • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...